Hepatitis B drug approval marks a significant milestone in treatment options for patients, offering hope and proven efficacy.
Author: Alexander James
Cancer drug price update: NPPA caps margins at 30%
Cancer drug price update reveals NPPA’s new margin caps for 137 medicines effective November 9.
Korean obesity drug Offers Smart Choice Against Mounjaro
Korean obesity drug is here to challenge Mounjaro with a slimmer price tag and effective results.
FDA Approval of WELTRUZA: A Proven Solution for Patients
FDA approval of WELTRUZA marks a significant advancement in treatment options.
Lipocine stock surge: Is it the best investment now?
Lipocine stock surge is making waves after Health Canada approval. What does this mean for investors?
Drug price gaps: The Worst Proven Mark-ups Revealed
Drug price gaps are alarming, with some medicines marked up over 50 times. Discover the implications for consumers.
Anupam Rasayan Acquisition: A Smart Move for Growth
Anupam Rasayan acquisition marks a significant step in the pharma industry, enhancing capabilities and market reach.
Pre-approval submissions: The Best Proven Strategies
Pre-approval submissions are essential for pharma success. Discover proven strategies to enhance your submission process today.
Novo multiblockbusters launch: Best Proven Pharma Strategy
Novo multiblockbusters launch plans to introduce at least five new drugs by 2030, showcasing a strong commitment to innovation.
Drug Approval Process Made Simple: A Proven Guide
Drug approval process simplified with CDSCO’s new risk-based regulation approach.
